Literature DB >> 22869583

Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality.

Hisao Nagoshi1, Tomohiko Taki, Ichiro Hanamura, Masakazu Nitta, Takemi Otsuki, Kazuhiro Nishida, Keiko Okuda, Natsumi Sakamoto, Satoru Kobayashi, Mio Yamamoto-Sugitani, Yasuhiko Tsutsumi, Tsutomu Kobayashi, Yosuke Matsumoto, Shigeo Horiike, Junya Kuroda, Masafumi Taniwaki.   

Abstract

Chromosome 8q24 rearrangements are occasionally found in multiple myeloma and are associated with tumor progression. The 8q24 rearrangements were detected by FISH in 12 of 54 patients with multiple myeloma (22.2%) and in 8 of 11 multiple myeloma cell lines (72.7%). The breakpoints of 8q24 in 10 patients with multiple myeloma and in all multiple myeloma cell lines were assigned to a 360 kb segment, which was divided into 4 regions: approximately 120 kb centromeric to MYC (5' side of MYC), the region centromerically adjacent to PVT1 (~ 170 kb region, including MYC, of 5' side of PVT1), the PVT1 region, and the telomeric region to PVT1. PVT1 rearrangements were most common and found in 7 of 12 patients (58.3%) and 5 of 8 cell lines (62.5%) with 8q24 abnormalities. A combination of spectral karyotyping (SKY), FISH, and oligonucleotide array identified several partner loci of PVT1 rearrangements, such as 4p16, 4q13, 13q13, 14q32, and 16q23-24. Two novel chimeric genes were identified: PVT1-NBEA in the AMU-MM1 cell line harboring t(8;13)(q24;q13) and PVT1-WWOX in RPMI8226 cell line harboring der(16)t(16;22)ins(16;8)(q23;q24). The PVT1-NBEA chimera in which PVT1 exon 1 was fused to NBEA exon 2 and the PVT1-WWOX in which PVT1 exon 1 was fused to WWOX exon 9 were associated with the expression of abnormal NBEA and WWOX lacking their N-terminus, respectively. These findings suggest that PVT1 rearrangements may represent a novel molecular paradigm underlying the pathology of 8q24 rearrangement-positive multiple myeloma. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22869583     DOI: 10.1158/0008-5472.CAN-12-0213

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

Review 1.  Phosphorylation/de-phosphorylation in specific sites of tumor suppressor WWOX and control of distinct biological events.

Authors:  Shenq-Shyang Huang; Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-08

2.  Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element.

Authors:  Seung Woo Cho; Jin Xu; Ruping Sun; Maxwell R Mumbach; Ava C Carter; Y Grace Chen; Kathryn E Yost; Jeewon Kim; Jing He; Stephanie A Nevins; Suet-Feung Chin; Carlos Caldas; S John Liu; Max A Horlbeck; Daniel A Lim; Jonathan S Weissman; Christina Curtis; Howard Y Chang
Journal:  Cell       Date:  2018-05-03       Impact factor: 41.582

Review 3.  Long non-coding RNAs and MYC association in hematological malignancies.

Authors:  Leonidas Benetatos; Agapi Benetatou; Georgios Vartholomatos
Journal:  Ann Hematol       Date:  2020-07-04       Impact factor: 3.673

Review 4.  Molecular characterization of common fragile sites as a strategy to discover cancer susceptibility genes.

Authors:  Larissa Savelyeva; Lena M Brueckner
Journal:  Cell Mol Life Sci       Date:  2014-09-18       Impact factor: 9.261

5.  Recurrent intragenic exon rearrangements of SOBP and AUTS2 in non-Hodgkin B-cell lymphoma.

Authors:  Yosuke Matsumoto; Yoshiaki Chinen; Yuji Shimura; Hisao Nagoshi; Nana Sasaki; Ayako Muramatsu; Kodai Kuriyama; Muneo Ohshiro; Yoshiko Hirakawa; Toshiki Iwai; Hitoji Uchiyama; Tomohiko Taki; Shigeo Horiike; Junya Kuroda; Masafumi Taniwaki
Journal:  Int J Hematol       Date:  2019-11-04       Impact factor: 2.490

Review 6.  WWOX, large common fragile site genes, and cancer.

Authors:  Ge Gao; David I Smith
Journal:  Exp Biol Med (Maywood)       Date:  2015-01-16

7.  Global Inhibition with Specific Activation: How p53 and MYC Redistribute the Transcriptome in the DNA Double-Strand Break Response.

Authors:  Joshua R Porter; Brian E Fisher; Laura Baranello; Julia C Liu; Diane M Kambach; Zuqin Nie; Woo Seuk Koh; Ji Luo; Jayne M Stommel; David Levens; Eric Batchelor
Journal:  Mol Cell       Date:  2017-08-31       Impact factor: 17.970

8.  miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast cancer.

Authors:  Xiaoyan Liu; Lei Bi; Qin Wang; Mingxin Wen; Ce Li; Yidan Ren; Qinlian Jiao; Jian-Hua Mao; Chuanxin Wang; Guangwei Wei; Yunshan Wang
Journal:  Oncogene       Date:  2018-03-20       Impact factor: 9.867

Review 9.  WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.

Authors:  C Marcelo Aldaz; Brent W Ferguson; Martin C Abba
Journal:  Biochim Biophys Acta       Date:  2014-06-14

Review 10.  The BEACH is hot: a LYST of emerging roles for BEACH-domain containing proteins in human disease.

Authors:  Andrew R Cullinane; Alejandro A Schäffer; Marjan Huizing
Journal:  Traffic       Date:  2013-04-24       Impact factor: 6.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.